BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 33087933)

  • 1. Cancer immunotherapy via targeted TGF-β signalling blockade in T
    Li S; Liu M; Do MH; Chou C; Stamatiades EG; Nixon BG; Shi W; Zhang X; Li P; Gao S; Capistrano KJ; Xu H; Cheung NV; Li MO
    Nature; 2020 Nov; 587(7832):121-125. PubMed ID: 33087933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β suppresses type 2 immunity to cancer.
    Liu M; Kuo F; Capistrano KJ; Kang D; Nixon BG; Shi W; Chou C; Do MH; Stamatiades EG; Gao S; Li S; Chen Y; Hsieh JJ; Hakimi AA; Taniuchi I; Chan TA; Li MO
    Nature; 2020 Nov; 587(7832):115-120. PubMed ID: 33087928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.
    Dodagatta-Marri E; Meyer DS; Reeves MQ; Paniagua R; To MD; Binnewies M; Broz ML; Mori H; Wu D; Adoumie M; Del Rosario R; Li O; Buchmann T; Liang B; Malato J; Arce Vargus F; Sheppard D; Hann BC; Mirza A; Quezada SA; Rosenblum MD; Krummel MF; Balmain A; Akhurst RJ
    J Immunother Cancer; 2019 Mar; 7(1):62. PubMed ID: 30832732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells.
    Gorham JD; Güler ML; Fenoglio D; Gubler U; Murphy KM
    J Immunol; 1998 Aug; 161(4):1664-70. PubMed ID: 9712029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy.
    Zhang L; Yu Z; Muranski P; Palmer DC; Restifo NP; Rosenberg SA; Morgan RA
    Gene Ther; 2013 May; 20(5):575-80. PubMed ID: 22972494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
    Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
    Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea.
    Haneda K; Sano K; Tamura G; Shirota H; Ohkawara Y; Sato T; Habu S; Shirato K
    Am J Respir Cell Mol Biol; 1999 Aug; 21(2):268-74. PubMed ID: 10423411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of TGF-β and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors.
    Bu MT; Chandrasekhar P; Ding L; Hugo W
    Pharmacol Ther; 2022 Dec; 240():108211. PubMed ID: 35577211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
    Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
    J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.
    Weiner HL
    Immunol Rev; 2001 Aug; 182():207-14. PubMed ID: 11722636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni.
    Tallima H; Salah M; Guirguis FR; El Ridi R
    Cytokine; 2009 Dec; 48(3):239-45. PubMed ID: 19717308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8
    Zhang Q; Helfand BT; Carneiro BA; Qin W; Yang XJ; Lee C; Zhang W; Giles FJ; Cristofanilli M; Kuzel TM
    Eur Urol; 2018 May; 73(5):648-652. PubMed ID: 29275833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of TGF-β signaling: a potential target for cancer immunotherapy?
    Ungefroren H
    Expert Opin Ther Targets; 2019 Aug; 23(8):679-693. PubMed ID: 31232607
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β.
    Lan Y; Zhang D; Xu C; Hance KW; Marelli B; Qi J; Yu H; Qin G; Sircar A; Hernández VM; Jenkins MH; Fontana RE; Deshpande A; Locke G; Sabzevari H; Radvanyi L; Lo KM
    Sci Transl Med; 2018 Jan; 10(424):. PubMed ID: 29343622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models.
    Sow HS; Ren J; Camps M; Ossendorp F; Ten Dijke P
    Cells; 2019 Apr; 8(4):. PubMed ID: 30959852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapy.
    Bialkowski L; Van der Jeught K; Bevers S; Tjok Joe P; Renmans D; Heirman C; Aerts JL; Thielemans K
    Int J Cancer; 2018 Aug; 143(3):686-698. PubMed ID: 29464699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.